Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents

Navigating postfellowship burdens with the help of mentors

Rahul N. Doshi, MD, FACC, FHRS

Business of Cardiology

Medicare episode payment models still evolving

Erik G. Stilp, MD, FACC; L. Samuel Wann, MD, MACC, FESC

Cover Story

Elderly patients present management, treatment challenges for cardiologists

FDA News

Combination drug approved for CV prevention in patients at risk for gastric ulcers

In the Journals

Genetic tests may be misdiagnosing hypertrophic cardiomyopathy in black Americans

Internet, mobile devices can improve healthy lifestyle choices

Women, men undergoing PCI have similar outcomes after short vs. prolonged DAPT

Folic acid-fortified foods associated with reduced risk for congenital heart defects

Thousands of genes responsible for inherited risk for MI, stroke identified in specific tissues

Late-onset asthma may increase risk for CV events

RESTORE SR: Vanoxerine effective for AF, but harmful in certain patients

Review: Benefits of statins outweigh harms

Risk for aortic aneurysm increases with psoriasis severity

Two measures may predict aortic regurgitation, mortality after TAVR

Societies: CAD best diagnosed, managed with myocardial perfusion PET

Neurostimulation device shows promise for treatment of central sleep apnea

Analysis: PCSK9 inhibitors not cost-effective, could greatly increase US health care costs

Beta-blockers fail to improve outcomes, may raise HF risk after PCI

Cardiac tamponade rates increasing among recipients of permanent pacemakers

Anemia, iron deficiency common in patients with chronic HF

Coronary CTA provides valuable CAD risk stratification in patients with diabetes

Adults with HIV, depression at elevated risk for MI

Sugar industry sponsored research to downplay sugar's role in heart disease

Industry News

Hacking vulnerability allegations spawn St. Jude Medical suit, FDA investigation

Meeting News Coverage

SAVE: CPAP does not reduce CV events in patients with CVD, sleep apnea

NORSTENT: DES not superior to BMS for death, MI in patients undergoing PCI

ENSURE-AF: Edoxaban noninferior to standard anticoagulation before cardioversion in patients with AF

PRAGUE-18: Prasugrel, ticagrelor confer similar outcomes in patients with STEMI undergoing PCI

BASKET-SAVAGE: DES superior to BMS for revascularization of saphenous vein grafts

CLARIFY: Low BP linked with adverse CV outcomes in high-risk patients

DOCTORS: OCT-guided PCI associated with better outcomes than standard PCI

ESC position paper addresses cardiotoxicity of cancer therapies

IV stem cell treatment safe, effective in patients with nonischemic HF

Bone marrow stem cells harvested from patient may improve angina

Trial Scorecards

Trial Scorecard: OPTICARE

Trial Scorecard: TRIBE-AKI

Trial Scorecard: RESTORE SR

Trial Scorecard: ABSORB II

Trial Scorecard: IPSYS

Trial Scorecard: ATACH-2

Trial Scorecard: CYRUS

Trial Scorecard: SAVE